Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details
Completed

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

NCT03473756

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago, Illinois, United States
  • Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 30 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

NCT03173560

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Innovative Clinical Research Institute, LLC Whittier, California, United States
  • Baptist Health Medical Group Oncology, LLC - US Oncology Miami, Florida, United States
  • Optimal Research Honolulu, Hawaii, United States
View all 93 locations
View Trial Details
Completed

Description of the Population With Genitourinary Tumors and COVID-19

NCT04578132

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +27 more
Locations
  • Institut Català d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Althaia Manresa, Barcelona, Spain
  • Hospital Universitari Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Universitario Puerta de Hierro-Majadahonda Majadahonda, Madrid, Spain
View all 32 locations
View Trial Details

Related conditions